Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review.

Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review.

Item
http://www.wikidata.org/entity/Q34111049
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in miceInhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme.Evaluation and management of dyslipidemia in patients with HIV infection.Intermuscular and subcutaneous adipose tissue distributions differ in HIV+ versus HIV-men and womenA cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapySimplified regimens for treating HIV infection and AIDS.Cardiovascular disease in HIV infection.New options in the treatment of lipid disorders in HIV-infected patients.Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients.Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly.HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.
P2860

Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review.

Item
http://www.wikidata.org/entity/Q34111049
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@ast
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@en
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@nl
type
label
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@ast
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@en
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@nl
prefLabel
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@ast
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@en
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P577
P698
P356
P1433
P1476
Metabolic disorders among HIV- ...... protease inhibitors: a review.
@en
P2093
P304
P31
P356
10.1097/00042560-200010001-00002
P407
P478
P577
P698